Elacestrant dihydrochloride

Elacestrant dihydrochloride (sold as Orserdu) is an oral Selective Estrogen Receptor Degrader (SERD) approved to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. It is indicated for postmenopausal women and men whose disease progressed after endocrine therapy, acting by binding to and degrading estrogen receptors

Anant Labs manufacture and furnish high quality Elacestrant dihydrochloride impurities for global markets. Our Elacestrant dihydrochloride EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.